image
Werewolf Therapeutics, Inc. HOWL
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 1.08
-5.26 %
$ 48.5 M
Market Cap
-0.66
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
149.65%
EBIT Estimate
33.21%
Net Income Estimate
3.83%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Werewolf Therapeutics, Inc.
image
HOWL has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart HOWL

image
$80.0m$80.0m$70.0m$70.0m$60.0m$60.0m$50.0m$50.0m$40.0m$40.0m$30.0m$30.0m$20.0m$20.0m$10.0m$10.0m$0.0$0.02022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart HOWL

image
$10.0m$10.0m$0.0$0.0($10.0m)($10.0m)($20.0m)($20.0m)($30.0m)($30.0m)($40.0m)($40.0m)($50.0m)($50.0m)($60.0m)($60.0m)($70.0m)($70.0m)2022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart HOWL

image
$0.0$0.0($10.0m)($10.0m)($20.0m)($20.0m)($30.0m)($30.0m)($40.0m)($40.0m)($50.0m)($50.0m)($60.0m)($60.0m)($70.0m)($70.0m)($80.0m)($80.0m)($90.0m)($90.0m)2022202220232023202420242025202520262026202720272028202820292029